Keeping Current

By Medscape PodcastsMedicine Health & Fitness

Keeping Current episodes

March 30, 2023 Biosimilars in Multiple Sclerosis: Entering a New Era of Biologic Therapy
Did you know what the inherent variability of all biologics and what degree of variation are acceptable by regulatory bodies?

Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/989395?src=mkm_podcast_addon_989395

38 min
March 29, 2023 Are We Ready for Biosimilars in Multiple Sclerosis? Experts Discuss Lessons From Other Immune-Mediated Diseases
What is the clinical use of biosimilars and how to best communicate with patients to avoid the nocebo effect?

Credit available for this activity expires: 3/29/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990193?ecd=bdc_podcast_libsyn_mscpedu
35 min
March 29, 2023 Global Perspectives on Anti-Vascular Endothelial Growth Factor: If, When, and How to Switch
Do you reload when switching? What intervals do you extend by? How long is feasible between treatments, and how do you monitor? Learn from the experts. Credit available for this activity expires: 28/03/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990120?ecd=bdc_podcast_libsyn_mscpedu
1 hr 2 min
March 28, 2023 Clinical Trials in Focus: Durability of Intravitreal Anti-Vascular Endothelial Growth Factor Therapies
Do you know how study designs influence the data with anti-vascular endothelial growth factor (anti-VEGF) therapies? Find out more.

Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/[ArticleID]?src=mkm_podcast_addon_989801

35 min
March 27, 2023 Safeguarding the CKD Patient With or Without Diabetes in Primary Care: Quick Questions, Rapid Replies
Did you know that SGLT2 blockade can reduce progression to ESKD by at least a decade in patients with mild-to-moderately decreased eGFR?

Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990093?ecd=bdc_podcast_libsyn_mscpedu
18 min
March 27, 2023 Optimizing Treatments in Advanced Systemic Mastocytosis With Associated Hematological Neoplasm
Do you know which you should be treating first -- the systemic mastocytosis (SM) or the associated hematological neoplasm (AHN)? Credit available for this activity expires: 3/24/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990024?ecd=bdc_podcast_libsyn_mscpedu
37 min
March 24, 2023 Diabetes Dialogue Part 2: Who Are Candidates for GLP-1 Receptor Agonist Therapy in Primary Care?
Who should be taking a glucagon-like peptide-1 (GLP-1) receptor agonist (RA)? Join Drs Bain and Lin to find out.

Credit available for this activity expires: 3/23/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/989998?ecd=bdc_podcast_libsyn_mscpedu
19 min
March 23, 2023 Challenging the Harmful Myths About ASCVD Management: The Experts Set the Record Straight
Do you know the latest information about dyslipidemia and atherosclerotic cardiovascular disease (ASCVD) risk? Drs Navar and Ray discuss. Credit available for this activity expires: 03/21/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/[989864]?ecd=bdc_podcast_libsyn_mscpedu
22 min
March 16, 2023 What Is the Expert Accord on Identifying and Protecting the Patient at Early Stage of CKD?
Did you know that early diabetic kidney disease may reduce the life expectancy of patients by 16 years?

Credit available for this activity expires: 3/14/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/989288?ecd=bdc_podcast_libsyn_mscpedu
38 min
March 16, 2023 Optimizing Adjuvant Treatment of Early Breast Cancer: Where Are We Today?
PARP inhibitors, CDK4/6 inhibitors, immunotherapy, and SERDS: Can you select optimal treatments for early breast cancer (EBC)? And what might be the consensus at St. Gallen? Credit available for this activity expires: 03/15/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/989483?ecd=bdc_podcast_libsyn_mscpedu
28 min